Oxytocin enhances the prolactin response to vasoactive intestinal polypeptide in healthy women

Fertility and Sterility

Volumn 70, Issue 3, 1998, Pages 541-543

  Chiodera, Paolo ^a,b   Volpi, Riccardo ^b   Capretti, Luigi ^c   Coiro, Vittorio ^b  

^a UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c Endocrine Unit

Author keywords

Oxytocin; Prolactin; Vasoactive intestinal polypeptide

Indexed keywords

OXYTOCIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; CELL STIMULATION; CENTRAL NERVOUS SYSTEM FUNCTION; FEMALE; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MENSTRUAL CYCLE; MESSENGER RNA SYNTHESIS; NEUROTRANSMITTER RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PULSATILE FLOW; SUCKLING;

ADULT; ANALYSIS OF VARIANCE; DRUG SYNERGISM; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MENSTRUAL CYCLE; OXYTOCIN; PROLACTIN; REFERENCE VALUES; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0031669860     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00202-7     Document Type: Article

References (4)

1. Richard P, Moos F, Freund-Mercier MJ. Central effects of oxytocin. Physiol Rev 1991;71:331-70.
2. Escalada J, Cacicedo L, Ortego J, Melian E, Sanchez-Franco F. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide. Endocrinology 1996;137:631-7.
3. Prysor-Jones RA, Jenkins JS. Vasoactive intestinal peptide and anterior pituitary function. Clin Endocrinol 1988;29:677-88.
4. Chiodera P, Volpi R, Gramellini D, Cigarini C, Corradi A, Cavazzini U, et al. Oxytocin does not modify the prolactin response to metoclopramide in normal women. J Endocrinol Invest 1991;14:463-8.